Wang Yu1, Sun Luying, Wang Haiyan, Li Xiaomei. 1. Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, No. 8, Xishiku Street, 100034 Beijing, China.
Abstract
AIM: Several studies have suggested that sodium intake may affect blood pressure (BP), proteinuria, and intrarenal transforming growth factor-β1 (TGF-β1) production in patients and animal models with chronic kidney disease (CKD). The Chinese population has a high prevalence of CKD and is well known for consuming salty foods. This study will investigate the role of dietary sodium intake on BP control among non-dialysis Chinese CKD patients. METHODS: A cross-sectional study was carried out in a cohort of 176 non-dialysis hypertensive CKD patients to investigate their sodium intake and its effect on BP control by measuring 24-h urine sodium excretion (24-h UNa). A total of 20 patients with immunoglobulin A nephropathy (IgAN) participated in a 7-day sodium restriction study (100 mmol/day). Their changes in BP, proteinuria, and urinary TGF-β1 excretion were subsequently analyzed. Another 23 IgAN patients without salt restriction were included as controls. RESULTS: The average 24-h UNa of the study cohort was 149.0 ± 66.4 mmol/day. Only 31.8% patients had a 24-h UNa less than 100 mmol/day. The OR for each 17 mmol increment in 24-h UNa (salt 1 g/day) for BP > 130/80 mmHg was 1.26 (95% CI 1.10-1.44, P = 0.001). The sodium restriction group achieved significantly more reduction in SBP (-11.1 mmHg vs. -5.0 mmHg, P = 0.022), DBP (-9.4 mmHg vs. -2.1 mmHg, P = 0.009), and urine protein excretion [-465 (-855 to -340) mg/day vs. -150 (-570 to 40) mg/day, P = 0.024]. A positive correlation was observed between the change of 24-h UNa and the change of SBP (r = 0.450, P = 0.047) in the sodium restriction group. The change of 24-h UNa was also correlated with the 24-h TGF-β1 excretion (r = 0.558, P = 0.011) in these patients. CONCLUSION: Dietary sodium intake restriction should be monitored and intensified in the treatment of Chinese CKD patients.
AIM: Several studies have suggested that sodium intake may affect blood pressure (BP), proteinuria, and intrarenal transforming growth factor-β1 (TGF-β1) production in patients and animal models with chronic kidney disease (CKD). The Chinese population has a high prevalence of CKD and is well known for consuming salty foods. This study will investigate the role of dietary sodium intake on BP control among non-dialysis Chinese CKDpatients. METHODS: A cross-sectional study was carried out in a cohort of 176 non-dialysis hypertensiveCKDpatients to investigate their sodium intake and its effect on BP control by measuring 24-h urine sodium excretion (24-h UNa). A total of 20 patients with immunoglobulin A nephropathy (IgAN) participated in a 7-day sodium restriction study (100 mmol/day). Their changes in BP, proteinuria, and urinary TGF-β1 excretion were subsequently analyzed. Another 23 IgANpatients without salt restriction were included as controls. RESULTS: The average 24-h UNa of the study cohort was 149.0 ± 66.4 mmol/day. Only 31.8% patients had a 24-h UNa less than 100 mmol/day. The OR for each 17 mmol increment in 24-h UNa (salt 1 g/day) for BP > 130/80 mmHg was 1.26 (95% CI 1.10-1.44, P = 0.001). The sodium restriction group achieved significantly more reduction in SBP (-11.1 mmHg vs. -5.0 mmHg, P = 0.022), DBP (-9.4 mmHg vs. -2.1 mmHg, P = 0.009), and urine protein excretion [-465 (-855 to -340) mg/day vs. -150 (-570 to 40) mg/day, P = 0.024]. A positive correlation was observed between the change of 24-h UNa and the change of SBP (r = 0.450, P = 0.047) in the sodium restriction group. The change of 24-h UNa was also correlated with the 24-h TGF-β1 excretion (r = 0.558, P = 0.011) in these patients. CONCLUSION: Dietary sodium intake restriction should be monitored and intensified in the treatment of Chinese CKDpatients.
Authors: Rajiv Saran; Robin L Padilla; Brenda W Gillespie; Michael Heung; Scott L Hummel; Vimal Kumar Derebail; Bertram Pitt; Nathan W Levin; Fansan Zhu; Samer R Abbas; Li Liu; Peter Kotanko; Philip Klemmer Journal: Clin J Am Soc Nephrol Date: 2017-02-16 Impact factor: 8.237
Authors: Matthew R Weir; Raymond R Townsend; Jeffrey C Fink; Valerie Teal; Stephen M Sozio; Cheryl A Anderson; Lawrence J Appel; Sharon Turban; Jing Chen; Jiang He; Natasha Litbarg; Akinlolu Ojo; Mahboob Rahman; Leigh Rosen; Susan Steigerwalt; Louise Strauss; Marshall M Joffe Journal: Am J Nephrol Date: 2012-10-12 Impact factor: 3.754
Authors: Muhammad R Toor; Anjali Singla; Jin K Kim; Xenia Sumin; Maria V DeVita; Michael F Michelis Journal: Int Urol Nephrol Date: 2014-06-20 Impact factor: 2.370
Authors: Shin-Young Ahn; Sejoong Kim; Dong Ki Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim; Suhnggwon Kim; Ho Jun Chin Journal: J Korean Med Sci Date: 2014-09-30 Impact factor: 2.153